NCT03594084

Brief Summary

The primary purpose is to describe the anamnestic, clinical, biological, and therapeutic characteristics of imported malaria in people originated from endemic areas. Indeed, clinicians have observed that people from such areas start malaria just after their arrival in France. Such observation needed to be confirmed. In addition, The investigators observed a variation in the laboratory diagnostic performance of malaria between hospital and private laboratories. Such observation also needed to be analyzed objectively

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 20, 2018

Completed
12 days until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

September 17, 2018

Status Verified

July 1, 2018

Enrollment Period

1 year

First QC Date

July 10, 2018

Last Update Submit

September 13, 2018

Conditions

Malaria

Keywords

MalariaMalaria imported casesRecurrent malariaEndemic malaria areasBiological diagnosisHospital vs private laboratory diagnosis

Outcome Measures

Primary Outcomes (1)

  • Study of clinical characteristics of imported malaria in people originated from endemic areas hospitalized at Strasbourg University Hospital from 2017 to 2018.

    The period from January 1st, 2017 to January 1st, 2018 will be examined

Eligibility Criteria

Age1 Day+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

iagnosis patients with malaria from 01/01/2017 to 01/01/2018

You may qualify if:

  • Patients from birth to 18 years
  • Patient submitted to guardianship
  • Patient submitted to trusteeship
  • Diagnosis patients with malaria from 01/01/2017 to 01/01/2018
  • Patient or legal representative agree to use medical data for this research

You may not qualify if:

  • Lack of confirmation malaria diagnosis
  • Impossibility to inform patients
  • Patient who does not wish to participate in the study
  • Patient submitted to justice safeguarding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Maladies Infectieuses et Tropicales

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

Malaria

Condition Hierarchy (Ancestors)

Protozoan InfectionsParasitic DiseasesInfectionsMosquito-Borne DiseasesVector Borne Diseases

Study Officials

  • Xavier ARGEMI, MD

    University Hospital, Strasbourg, France

    STUDY DIRECTOR

Central Study Contacts

Xavier ARGEMI, MD

CONTACT

33 3 69 55 11 87xavier.argemi@chru-strasbourg.fr

Anne DINDOYAL, MD

CONTACT

33 3 69 55 11 87anne.dindoyal@chru-strasbourg.fr

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2018

First Posted

July 20, 2018

Study Start

August 1, 2018

Primary Completion

August 1, 2019

Study Completion

August 1, 2019

Last Updated

September 17, 2018

Record last verified: 2018-07

Locations

FR(1)